Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02023606Phase 1Completed
Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M
Impulsive Aggression Comorbid With ADHD
Principalinvestigator
NCT02319772Phase 1Completed
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430
Ebola Virus InfectionFilovirus Infections
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Deborah Watson-Jones, PhD

London School of Hygiene and Tropical Medicine

Related
4 trials

Shared therapeutic areas:

Hemorrhagic Fever, EbolaFiloviridae Infections
Similarity Score20%

Mark Kieh

Redemption Hospital

Related
1 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score10%

Bailah Leigh, MD

University of Sierra Leone

Related
2 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score10%

Tuan Le, MD

Oklahoma Blood Institute

Related
1 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score10%

John M Griffiss, MD

Clinical Research Management

Related
1 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score10%

Michael C Sneller, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
12 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score10%

Angela Huttner, MD

University of Geneva, Switzerland

Related
2 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola
Similarity Score10%

Myron M Levine, MD, DTPH

University of Maryland, Baltimore

Related
2 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score10%

Richard T Davey, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
10 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score10%

Stephen B. Kennedy

Redemption Hospital

Related
1 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02023606Phase 1PrincipalInvestigator

Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M

Impulsive Aggression Comorbid With ADHD
Completed
NCT02319772Phase 1PrincipalInvestigator

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

Ebola Virus InfectionFilovirus Infections
Completed

All 2 trials loaded